Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹71.4 Cr -3.7% 0.8% -43.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,224.8 Cr -5% 5.4% -3.4% Stock Analytics
KIRI INDUSTRIES ₹2,746.6 Cr -0.1% -11.1% -21.8% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,592.8 Cr 2.9% -2.7% -29.9% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,147.2 Cr 1.6% 8.1% 26.7% Stock Analytics
BODAL CHEMICALS ₹605.2 Cr -5.3% -2% -24.7% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

-3.7%

0.8%

-43.1%

SENSEX

-1%

-0.1%

7.9%


You may also like the below Video Courses